Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Placenta

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    50 result(s) found for: Placenta. Displaying page 1 of 3.
    1  2  3  Next»
    EudraCT Number: 2008-008489-11 Sponsor Protocol Number: PHRI08-FP/PLACENTA ACCRETA Start Date*: 2009-04-22
    Sponsor Name:CHRU de TOURS
    Full Title: Placenta accreta : analyse en échographie de contraste en population à haut risque
    Medical condition: grossesse pathologique placenta praevia et utérus cicatriciel / placenta praevia et plus de 35 ans placenta accreta
    Disease: Version SOC Term Classification Code Term Level
    9.1 10035119 Placenta praevia LLT
    9.1 10062936 Placenta accreta LLT
    Population Age: Adults Gender: Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-003810-42 Sponsor Protocol Number: Version2.0;18/12/2013 Start Date*: 2016-06-24
    Sponsor Name:University of Edinburgh (ACCORD) [...]
    1. University of Edinburgh (ACCORD)
    2. NHS Lothian (ACCORD)
    Full Title: A pragmatic group sequential placebo controlled randomised trial to determine the effectiveness of Glyceryl trinitrate for retained placenta (GOT-IT Trial)
    Medical condition: Retained placenta
    Disease: Version SOC Term Classification Code Term Level
    16.1 100000004868 10038757 Retained placenta LLT
    16.1 100000004865 10038350 Removal retained placenta LLT
    Population Age: Adolescents, Under 18, Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2008-001346-92 Sponsor Protocol Number: Nitroglycerin2 Start Date*: 2008-05-23
    Sponsor Name:No sponsor
    Full Title: Medical treatment with nitroglycerin for management of retained placenta - a multicentre trial
    Medical condition: Background: retained placenta occurs in 3% of all deliveries. The results from a pilot study indicate that medical treatment with a combination of oxytocin and the utero-relaxing agent nitroglycer...
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: SE (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-023597-39 Sponsor Protocol Number: HOPPE-Trial Start Date*: 2011-04-11
    Sponsor Name:Lluís Cabero Roura
    Full Title: HEPARINA DE BAJO PESO MOLECULAR (HBPM) para la prevención de complicaciones derivadas de la insuficiencia placentaria en las pacientes de riesgo sin trombofilia: ensayo clínico multicéntrico random...
    Medical condition: Complicaciones de la gestación derivadas de la insuficiencia placentaria: preeclampsia, restricción de crecimiento intrauterino, desprendimiento de placenta normalmente inserta y óbito fetal.
    Disease: Version SOC Term Classification Code Term Level
    13 10027621 Preeclampsia leve o no especificada, anteparto LLT
    13 10035138 Insuficiencia placentaria LLT
    13 10036569 Circunstancias relacionadas con el embarazo HLT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed)
    Trial results: View results
    EudraCT Number: 2006-006371-20 Sponsor Protocol Number: Start Date*: 2007-11-30
    Sponsor Name:LUMC
    Full Title: Misoprostol in the management of retained placenta, a safe alternative for manual removal? A randomised controlled trial.
    Medical condition: To assess the effectiveness of misoprostol in the management of retained placenta. Will 800 micrograms of misoprostol orally reduce the need for manual removal under general anaesthesia and prove t...
    Disease: Version SOC Term Classification Code Term Level
    8.1 10017847 Gastric ulcers and perforation HLT
    Population Age: Adults Gender: Female
    Trial protocol: NL (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2010-022715-19 Sponsor Protocol Number: 27061954 Start Date*: 2010-12-20
    Sponsor Name:Universitetssjukhuset Linköping
    Full Title: Inflammation och koagulation vid habituell abort
    Medical condition: Upprepade missfall definieras som 3 eller fler konsekutiva spontana missfall. Incidensen av upprepade missfall är 1% och hos hälften påvisas ingen sannolik orsak (=RSA). Studier har visat att hos k...
    Disease: Version SOC Term Classification Code Term Level
    12.1 10018809 Habitual abortion (spontaneous) LLT
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2013-005036-20 Sponsor Protocol Number: VEK40624 Start Date*: 2014-02-18
    Sponsor Name:Stellaris Pharmaceuticals ApS
    Full Title: Recombinant Factor VIIa: Local treatment of severe postpartum hemorrhage
    Medical condition: Severe postpartum bleeding
    Disease: Version SOC Term Classification Code Term Level
    16.1 100000004868 10071867 Postpartum bleeding LLT
    16.1 100000004868 10071897 Third stage postpartum bleeding LLT
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2012-005511-11 Sponsor Protocol Number: SPON1155-12 Start Date*: 2013-05-07
    Sponsor Name:RACD Cardiff University
    Full Title: Fibrinogen concentrate versus placebo for treatment of postpartum haemorrhage: a prospective double blind randomised control trial
    Medical condition: Postpartum haemorrhage
    Disease: Version SOC Term Classification Code Term Level
    14.1 10036585 - Pregnancy, puerperium and perinatal conditions 10036294 Postpartum haemorrhage (primary) LLT
    14.1 10036585 - Pregnancy, puerperium and perinatal conditions 10043454 Third-stage postpartum haemorrhage LLT
    14.1 10036585 - Pregnancy, puerperium and perinatal conditions 10036417 Postpartum haemorrhage PT
    14.1 10036585 - Pregnancy, puerperium and perinatal conditions 10043449 Third stage postpartum haemorrhage PT
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2012-000622-22 Sponsor Protocol Number: ASAP Start Date*: 2012-07-20
    Sponsor Name:Fundació Clínic per a la Recerca Biomèdica
    Full Title: Aspirin for the enhancement of trophoblastic invasion in women with abnormal uterine artery Doppler at 11-14 weeks of gestation
    Medical condition: Placental insufficiency
    Disease: Version SOC Term Classification Code Term Level
    14.1 10036585 - Pregnancy, puerperium and perinatal conditions 10035138 Placental insufficiency PT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2019-004439-22 Sponsor Protocol Number: CHUBX2018/64 Start Date*: 2020-03-12
    Sponsor Name:CHU de Bordeaux
    Full Title: TRAnexamic Acid for Preventing blood loss following a cesarean delivery in women with placenta pREVIA: a multicenter randomised, double blind placebo controlled trial (TRAAPrevia)
    Medical condition: Postpartum hemorrhage, placenta previa, prevention, blood loss, transfusion
    Disease: Version SOC Term Classification Code Term Level
    20.1 10036585 - Pregnancy, puerperium and perinatal conditions 10036417 Postpartum haemorrhage PT
    20.0 10036585 - Pregnancy, puerperium and perinatal conditions 10036585 Pregnancy, puerperium and perinatal conditions SOC
    Population Age: Adults Gender: Female
    Trial protocol: FR (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2018-001829-11 Sponsor Protocol Number: UoL001337 Start Date*: 2018-10-04
    Sponsor Name:University of Liverpool
    Full Title: The Carboprost or Oxytocin Postpartum haemorrhage Effectiveness Study. Carboprost vs Oxytocin as the First Line Treatment of Primary Postpartum Haemorrhage; A phase IV, double-blind, double-dummy, ...
    Medical condition: Primary postpartum haemorrhage
    Disease: Version SOC Term Classification Code Term Level
    21.1 100000004868 10055323 Postpartum hemorrhage (primary) LLT
    Population Age: Adolescents, Under 18, Adults Gender: Female
    Trial protocol: GB (GB - no longer in EU/EEA)
    Trial results: (No results available)
    EudraCT Number: 2009-017736-41 Sponsor Protocol Number: 2009-315 Start Date*: 2010-04-20
    Sponsor Name:Anæstesiologisk Afd. Herlev Hospital
    Full Title: "Fibrinogen-koncentrat som initial behandling ved postpartum blødning"
    Medical condition: Postpartum blødning
    Disease: Version SOC Term Classification Code Term Level
    21.1 10036585 - Pregnancy, puerperium and perinatal conditions 10036296 Postpartum haemorrhage NOS LLT
    21.1 10036585 - Pregnancy, puerperium and perinatal conditions 10036294 Postpartum haemorrhage (primary) LLT
    21.1 10036585 - Pregnancy, puerperium and perinatal conditions 10043454 Third-stage postpartum haemorrhage LLT
    20.1 10036585 - Pregnancy, puerperium and perinatal conditions 10036417 Postpartum haemorrhage PT
    21.1 10036585 - Pregnancy, puerperium and perinatal conditions 10055864 Other immediate postpartum haemorrhage, postpartum LLT
    21.1 10036585 - Pregnancy, puerperium and perinatal conditions 10043449 Third stage postpartum haemorrhage PT
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2018-000964-27 Sponsor Protocol Number: WP2018 Start Date*: 2018-05-09
    Sponsor Name:Karolinska Institutet
    Full Title: Medical termination of pregnancy from day 85 to day 153 of gestation: A randomized comparison between administration of the initial dose of misoprostol at home or in the clinic
    Medical condition: Unwanted pregnancy
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: SE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2020-005552-38 Sponsor Protocol Number: ProFET Start Date*: 2021-01-27
    Sponsor Name:Västragötalandsregionen, Sahlgrenska Universitetssjukhuset
    Full Title: Vaginal progesterone as luteal support for improvement of live birth in frozen/thawed in-vitro fertilization natural cycles; a multicenter, open, randomized trial
    Medical condition: infertility
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: SE (Trial now transitioned) IS (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2021-005194-77 Sponsor Protocol Number: Matimmunestudyversion2 Start Date*: 2021-10-26
    Sponsor Name:University of Antwerp
    Full Title: The optimal timing of vaccination in pregnancy: a multi-dimensional mechanistic approach to measure immune responses in pregnant women
    Medical condition: humoral and cellular immune responses to pertussis vaccine during pregnancy
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: BE (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2022-001956-40 Sponsor Protocol Number: PK_pregnancy Start Date*: 2023-03-05
    Sponsor Name:Medical University Vienna
    Full Title: Antibiotic pharmacokinetics in women with twin pregnancy
    Medical condition: The target population are twin pregnancy women that will deliver through c-section and that are receiving one or more of the included antibiotics.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: AT (Trial now transitioned)
    Trial results: (No results available)
    EudraCT Number: 2014-003138-18 Sponsor Protocol Number: UCC-Strider Start Date*: Information not available in EudraCT
    Sponsor Name:University College Cork
    Full Title: STRIDER Ireland: A Randomised Controlled Trial of Sildenafil Therapy In Dismal Prognosis Early‐Onset Intrauterine Growth Restriction
    Medical condition: Severe early - onset Intrauterine Growth Restriction (IUGR), (also referred to as Fetal growth restriction) diagnosed between 22+0 and 29+6 gestational age. IUGR is defined as an estimated fetal we...
    Disease: Version SOC Term Classification Code Term Level
    19.0 100000004868 10070532 Fetal growth restriction LLT
    Population Age: Adolescents, Under 18, Adults Gender: Female
    Trial protocol: IE (Prematurely Ended)
    Trial results: View results
    EudraCT Number: 2013-002484-26 Sponsor Protocol Number: FIDEL Start Date*: 2014-08-18
    Sponsor Name:LFB Biomédicaments
    Full Title: A RANDOMISED, MULTICENTRE, DOUBLE-BLIND, PLACEBO-CONTROLLED STUDY ON THE EFFICACY AND SAFETY OF A THERAPEUTIC STRATEGY OF POST PARTUM HAEMORRHAGE COMPARING EARLY ADMINISTRATION OF HUMAN FIBRINOGEN ...
    Medical condition: post partum haemorrhage following vaginal delivery
    Disease: Version SOC Term Classification Code Term Level
    18.0 100000004868 10036294 Postpartum haemorrhage (primary) LLT
    Population Age: Adults Gender: Female
    Trial protocol: FR (Completed)
    Trial results: View results
    EudraCT Number: 2007-000284-21 Sponsor Protocol Number: 524E-CVD-9101-004 Start Date*: 2007-11-08
    Sponsor Name:York Hospitals NHS Foundation Trust [...]
    1. York Hospitals NHS Foundation Trust
    2. University of York
    Full Title: A multicentre, multinational randomised control trial of prophylactic low molecular weight heparin(LMWH) in high risk pregnant thrombophilic women
    Medical condition: Thrombophilia in pregnancy. This is a multi-centre, multi-national randomised controlled trial of Low Molecular Weight Heparin to prevent pregnancy complications in high-risk pregnant thrombophi...
    Disease: Version SOC Term Classification Code Term Level
    14.0 10005329 - Blood and lymphatic system disorders 10057396 Thrombophilia LLT
    Population Age: Adults Gender: Female
    Trial protocol: GB (Completed)
    Trial results: View results
    EudraCT Number: 2006-006440-55 Sponsor Protocol Number: Amino Acid 01/2007 Start Date*: 2007-08-27
    Sponsor Name:University Childrin's Hospital
    Full Title: Effect on metabolic acidosis due to hyperammonemia of high versus low intake of amino acid in VLBW infants.
    Medical condition: At birth, a VLBW infant is abruptly disconnected from the ideal source of parenteral nutrition - the placenta. If the goal of post-natal nutrition in the VLBW infant is to mimic in utero nutrition....
    Disease: Version SOC Term Classification Code Term Level
    9.1 10063258 Amino acid level LLT
    Population Age: Preterm newborn infants, Under 18 Gender: Male, Female
    Trial protocol: DE (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Tue May 06 12:10:30 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA